Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

Reflects the promise of the novel Factor XI inhibitor class of medicines to help prevent strokes ... has entered into an agreement with Novartis to acquire Anthos for up to $3.1 billion. Anthos was ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

In a previous column, I discussed some common medications that can cause or worsen dry skin. In this column, we’ll look at three common medications that may contribute to hair loss or thinning by ...

Obesity significantly impacts cardiovascular health, increasing risks such as left ventricular hypertrophy, atherosclerosis, and hypertension. Pharmac ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of ... based cohort study using a new-user active comparator design. From 1 January 1990 to 30 April ...

Busà Photography / Getty Images Many people believe that being wealthy means having a nice house, a late-model car, and a summer cottage, but the kind of money possessed by the wealthiest 1% of ...

Skenes was selected as the NL's starting pitcher in the All-Star Game after just 11 starts and finished the season 11-3 with a 1.96 ERA in 23 games. Skenes said over the weekend he hasn't thought ...

Star sprinter Hima Das, who is gearing up for the new season after serving a 16-month suspension for a whereabouts failure, visited the Maha Kumbh and took a dip in the Holy Ganga, her spiritual ...

An 11-year-old could be in for a big prize after he uncovered some buried pirate treasure. Topps announced Tuesday that the youngster opened a pack containing a one-of-a-kind baseball card ...

It's most common among people with type 1 diabetes who take medication such as insulin to control their blood glucose. The drugs keep their blood sugar levels in such tight control that they rarely ...